ArticleFrontiers in medicine2026
A deep learning-based radiomic nomogram derived from visceral fat for early prediction of gastrointestinal stromal tumor risk grade.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastrointestinal stromal tumors (GISTs) show substantial heterogeneity and are classified into distinct risk categories requiring different treatment strategies. Therefore, reliable preoperative risk stratification is crucial for treatment planning. Due to its inherent contrast, visceral adipose tissue can be reliably segmented and its volume of interest (VOI) obtained even on non-contrast CT scans. Therefore, this study aimed to develop a deep-learning-based radiomics nomogram (DLRN) that integrates visceral adipose features extracted from non-contrast computed tomography (CT). The DLRN is designed to provide a convenient tool for the preoperative prediction of GIST risk grades, including for patients for whom contrast-enhanced imaging is not feasible. Patients and methods: A total of 211 patients with histologically confirmed GISTs from two institutions were included. The derivation cohort from Institution A ( Results: Among the evaluated models, the DLRN showed favorable discrimination in the derivation cohort and exploratory performance in the external test cohort. In the derivation cohort, it achieved an area under the curve (AUC) of 0.936 [95% confidence interval (CI): 0.8907-0.9812], accuracy of 0.873, sensitivity of 0.811, and specificity of 0.904. In the external test cohort, the AUC was 0.862 (95% CI: 0.6216-1.0000), with an accuracy of 0.925, a sensitivity of 0.833, and a specificity of 0.936. Decision curve analysis demonstrated that the DLRN provided a higher net clinical benefit than all comparison models in both datasets. Calibration curves showed the agreement between predicted probabilities and observed outcomes, while DeLong tests were used for pairwise AUC comparisons between models. Conclusion: The proposed DLRN, integrating visceral fat-derived radiomics and clinical variables, may provide a non-invasive adjunct for preoperative GIST risk stratification on non-contrast CT. Further validation in larger multicentre cohorts is still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.